Clinical Trials
2 trialsNCT01801670 2015-01-27
Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
Boston University
Withdrawn
NCT00430053 2012-03-15
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
National Institutes of Health Clinical Center (CC)
Completed